Today, breast care is not always effective, largely a one-size fits all approach, and struggles to keep up with demand. We provide accurate, human-centric, and economic solutions to empower your decisions in every step of the Breast Health Journey.
Mammography
Mammography systems and reading solutions provides the highest depth resolution to support diagnostic accuracy and enables personalized breast care – from screening to diagnostics to follow-up.
Ultrasound
Advancing healthcare by providing innovative, sustainable ultrasound solutions that empower clinicians to deliver exceptional care. Our systems enhance diagnostic confidence, streamline workflows, and improve patient access, helping to transform healthcare delivery and outcomes.
Breast MRI
Breast cancer is the most common cancer in women. On a global scale, every tenth woman is affected, and numbers continue to rise. MR imaging can help provide early and reliable diagnosis especially in difficult cases. It can support accurate preoperative staging and differential diagnosis, resulting in faster and more cost-effective patient management.
Recent advancements such as abbreviated MRI protocols and novel techniques for functional tissue classification are designed to further the reach and diagnostic capabilities of breast MRI in clinical practice.
Digital Health
Digitalization and automation are key to provide high-quality care and increase productivity in healthcare. It comprises business intelligence, performance management tools and tele operations solutions, innovative cardiology IT, digital pathology as well as diagnostics IT and lab automation.
Molecular Imaging
Clinical needs in oncology, neurology, cardiology, orthopaedics and radiology, our molecular imaging and nuclear medicine systems provide PET/CT, SPECT and hybrid SPECT/CT solutions to help clinicians diagnose, treat, and monitor disease confidently. With our preeminent engineering capabilities, each solution in our integrated portfolio is designed to make high-quality imaging exams easy, fast, and impactful at every stage of care.
Radiation Therapy
With anatomic-based planning, it may be difficult to differentiate between non-viable (low metabolic activity) and viable (high metabolic activity) parts of a tumor. This might result in target volumes that are too small or too large and can lead to radiation dose being delivered to healthy tissue. Molecular Imaging helps overcome these challenges by distinguishing between high metabolically active tumor regions and areas of necrosis for early, precise target volume definition, allowing the physician to improve dose escalation and treatment monitoring.